These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18035853)

  • 1. Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography-mass spectrometry (GC-MS).
    Zaitsu K; Katagi M; Kamata H; Kamata T; Shima N; Miki A; Iwamura T; Tsuchihashi H
    J Mass Spectrom; 2008 Apr; 43(4):528-34. PubMed ID: 18035853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography-mass spectrometry.
    Takahashi M; Nagashima M; Suzuki J; Seto T; Yasuda I; Yoshida T
    Talanta; 2009 Feb; 77(4):1245-72. PubMed ID: 19084633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs).
    Rösner P; Quednow B; Girreser U; Junge T
    Forensic Sci Int; 2005 Mar; 148(2-3):143-56. PubMed ID: 15639609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designer drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Ewald AH; Fritschi G; Maurer HH
    J Mass Spectrom; 2006 Sep; 41(9):1140-8. PubMed ID: 16810708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS.
    Kusano M; Zaitsu K; Nakayama H; Nakajima J; Hisatsune K; Moriyasu T; Matsuta S; Katagi M; Tsuchihashi H; Ishii A
    J Mass Spectrom; 2015 Mar; 50(3):586-91. PubMed ID: 25800195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of side chain isomers of ring-substituted amphetamines using gas chromatography/infrared/mass spectrometry (GC/IR/MS).
    Soine WH; Duncan W; Lambert R; Middleberg R; Finley H; O'Neil DJ
    J Forensic Sci; 1992 Mar; 37(2):513-27. PubMed ID: 1500896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of methoxybenzoylpiperazines (OMeBzPs) and methylenedioxybenzylpiperazines (MDBPs) By GC-IRD and GC-MS.
    Abdel-Hay KM; DeRuiter J; Clark CR
    Drug Test Anal; 2012 Jun; 4(6):430-40. PubMed ID: 22170873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ultra high performance liquid chromatography with time of flight detection for the identification of synthetic cannabinoids in seized drugs.
    Marginean I; Rowe WF; Lurie IS
    Forensic Sci Int; 2015 Apr; 249():83-91. PubMed ID: 25679986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
    Maresová V; Chadt J; Prikryl L
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a mass spectrometric hydroxyl-position determination method for the hydroxyindole metabolites of JWH-018 by GC-MS/MS.
    Kusano M; Zaitsu K; Yamanaka M; Hisatsune K; Asano T; Taki K; Hayashi Y; Tsuchihashi H; Ishii A
    J Mass Spectrom; 2016 May; 51(5):350-7. PubMed ID: 27194519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Methylphenylethylamines: common fragmentation pathways with amphetamines in electrospray ionization collision-induced dissociation.
    Brown DH; Hansson R; Oosthuizen F; Sumner N
    Drug Test Anal; 2016; 8(3-4):344-50. PubMed ID: 26015311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GC-MS and GC-IR Analyses of the Methoxy-1-n-pentyl-3-(1-naphthoyl)-indoles: Regioisomeric Designer Cannabinoids.
    Thaxton-Weissenfluh A; Belal TS; DeRuiter J; Smith F; Abiedalla Y; Neel L; Abdel-Hay KM; Clark CR
    J Chromatogr Sci; 2018 Oct; 56(9):779-788. PubMed ID: 29920587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of alkylpyrazines by gas chromatography mass spectrometry (GC-MS).
    Xu S; Errabelli R; Feener DH; Noble K; Attygalle AB
    J Chromatogr A; 2019 Mar; 1589():149-161. PubMed ID: 30655029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid method for the extraction, enantiomeric separation and quantification of amphetamines in hair.
    Strano-Rossi S; Botrè F; Bermejo AM; Tabernero MJ
    Forensic Sci Int; 2009 Dec; 193(1-3):95-100. PubMed ID: 19896309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural elucidation of amino amide-type local anesthetic drugs and their main metabolites in urine by LC-MS after derivatization and its application for differentiation between positional isomers of prilocaine.
    Weissberg A; Drug E; Prihed H; Madmon M; Shamai Yamin T
    J Mass Spectrom; 2020 Oct; 55(10):e4654. PubMed ID: 32970370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
    Frison G; Odoardi S; Frasson S; Sciarrone R; Ortar G; Romolo FS; Strano Rossi S
    Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1196-204. PubMed ID: 26395784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of chromatography and mass spectrometry for the differentiation of three series of positional isomers of 2-(dimethoxyphenyl)-N-(2-halogenobenzyl)ethanamines.
    Kupriyanova OV; Shevyrin VA; Shafran YM
    Drug Test Anal; 2022 Jun; 14(6):1102-1115. PubMed ID: 35106940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral separation of new cathinone- and amphetamine-related designer drugs by gas chromatography-mass spectrometry using trifluoroacetyl-l-prolyl chloride as chiral derivatization reagent.
    Mohr S; Weiß JA; Spreitz J; Schmid MG
    J Chromatogr A; 2012 Dec; 1269():352-9. PubMed ID: 23058937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.